Lori Firmani

Lori Firmani discloses dealings in Damora Therapeutics, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 3 January 2025 to 2 January 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 6 January 2026: an option exercise, in Damora Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.